AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Corporate Conference Call Abstracts)
CORPORATE CONFERENCE CALL ABSTRACTS-19 November 2004-OSI Pharmaceuticals Announces Conference Call On Earlier Announced FDA Approval Of Tarceva -TM- For Patients With Advanced Non-Small Cell Lung Cancer - Abstract (C)2004 Research and Markets (http://www.researchandmarkets.com/).
The OSI Pharmaceuticals, Inc. (OSIP) Corporate Conference Call took place on 19-Nov-04 …